Report overview
This report contains market size and forecasts of Diagnostic Biomarkers in Global, including the following market information:
Global Diagnostic Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diagnostic Biomarkers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Safety Biomarkers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diagnostic Biomarkers include Qiagen N.V., Perkinelmer, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC., Biosims Technologies Sas and Cisbio Bioassays, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diagnostic Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diagnostic Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diagnostic Biomarkers Market Segment Percentages, by Type, 2021 (%)
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Global Diagnostic Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Diagnostic Biomarkers Market Segment Percentages, by Application, 2021 (%)
Hospitals
Cancer Research Institutes
Diagnostic Labs
Global Diagnostic Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diagnostic Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diagnostic Biomarkers revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diagnostic Biomarkers revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Qiagen N.V.
Perkinelmer, Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
Enzo Biochem, Inc.
EKF Diagnostics Holdings, Inc.
Meso Scale Diagnostics, LLC.
Biosims Technologies Sas
Cisbio Bioassays
Signosis, Inc
Banyan Biomarkers, Inc
Biomedical Corp
